Roger Y. Tsang, MD, FRCPC
Clinical Assistant Professor
Cumming School of Medicine, Department of Oncology
Tom Baker Cancer Centre
Arnie Charbonneau Cancer Institute
Bachelor of Medical Science (BMSc) , University of Alberta, 2003
Doctor of Medicine (MD) with Special Training in Research , University of Alberta, 2004
Internal Medicine , Fellow of the Royal College of Physicians of Canada (FRCPC), 2008
Medical Oncology , Sub-Specialty Certification, Royal College of Physicians of Canada, 2009
Dr. Tsang is a staff medical oncologist at the cancer centre in Calgary. He obtained his MD with Special Training in Research at the University of Alberta, followed by Internal Medicine and Medical Oncology residency training in Edmonton. He completed a Translational Oncology research fellowship at UCLA in Los Angeles, California. Since 2018, he has served as a Medical Informatics Lead in Medical Oncology, Calgary Zone, with AHS Connect Care. In 2020, he received an Evidence-Based Medicine teaching award from the Medical Oncology residency training program.
Areas of Research
- Breast Cancer
- Neuro-Oncology (CNS Cancers)
Dr. Tsang is an active participant in local, cooperative group, and industry-sponsored research studies in breast and central nervous system (CNS) cancers. He is the site PI for Canadian Cancer Trials Group (CCTG) CEC.6 [ALLIANCE N0577], a phase III clinical trial evaluating temozolomide versus PCV chemotherapy in patients with 1p/19q co-deleted gliomas. He is a co-investigator in a phase I/II study evaluating niacin in patients with newly diagnosed glioblastoma, and a co-investigator in a breast cancer study evaluating the use of a novel microwave imaging technique in patients receiving neoadjuvant systemic therapy. He also serves as a physician member on the CCTG Audit and Monitoring Committee.
Are you the profile owner?
Login to edit.